Immunology

Rabies

Volumn , Issue , 2013, Pages 387-408

  Lafon, Monique ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Apoptosis; B7 H1; Brain; CD8 T cells; Experimental rabies; FasL; Immune evasive mechanism; Immuno unresponsiveness; Innate immune; Interferon; Nervous system; Neurite outgrowth; Neuro infiltration; Neuro survival; Neuroinflammation; Neuroinvasiveness; Neurons; PDL 1; Toll like receptors; Virulence

Indexed keywords

EID: 84883942304     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-396547-9.00010-9     Document Type: Chapter

References (126)

1. Baloul L., Camelo S., Lafon M. Up-regulation of Fas ligand (FasL) in the central nervous system: A mechanism of immune evasion by rabies virus. J Neurovirol 2004, 10(6):372-382.
2. Baloul L., Lafon M. Apoptosis and rabies virus neuroinvasion. Biochimie 2003, 85(8):777-788.
3. Barajon I., Serrao G., Arnaboldi F., Opizzi E., Ripamonti G., Balsari A., et al. Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem 2009, 57(11):1013-1023. doi: jhc.2009.953539 [pii] 10.1369/jhc.2009.953539.
4. Bechmann I., Galea I., Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol 2007, 28(1):5-11. doi: S1471-4906(06)00329-2 [pii] 10.1016/j.it.2006.11.007.
5. Blondel D., Kheddache S., Lahaye X., Dianoux L., Chelbi-Alix M.K. Resistance to rabies virus infection conferred by the PMLIV isoform. J Virol 2010, 84(20):10719-10726. doi: JVI.01286-10 [pii] 10.1128/JVI.01286-10.
6. Boivin G., Coulombe Z., Rivest S. Intranasal herpes simplex virus type 2 inoculation causes a profound thymidine kinase dependent cerebral inflammatory response in the mouse hindbrain. Eur J Neurosci 2002, 16(1):29-43.
7. Bottcher T., von Mering M., Ebert S., Meyding-Lamade U., Kuhnt U., Gerber J., et al. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci Lett 2003, 344(1):17-20.
8. Brown G.C., Neher J.J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 2010, 41(2-3):242-247. 10.1007/s12035-010-8105-9.
9. Brzozka K., Finke S., Conzelmann K.K. Identification of the rabies virus alpha/beta interferon antagonist: Phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 2005, 79(12):7673-7681.
10. Brzozka K., Finke S., Conzelmann K.K. Inhibition of interferon signaling by rabies virus phosphoprotein P: Activation-dependent binding of STAT1 and STAT2. J Virol 2006, 80(6):2675-2683.
11. Bsibsi M., Persoon-Deen C., Verwer R.W., Meeuwsen S., Ravid R., Van Noort J.M. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006, 53(7):688-695. 10.1002/glia.20328.
12. Camelo S., Lafage M., Galelli A., Lafon M. Selective role for the p55 Kd TNF-alpha receptor in immune unresponsiveness induced by an acute viral encephalitis. J Neuroimmunol 2001, 113(1):95-108.
13. Camelo S., Lafage M., Lafon M. Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis. J Neurovirol 2000, 6(6):507-518.
14. Cameron J.S., Alexopoulou L., Sloane J.A., DiBernardo A.B., Ma Y., Kosaras B., et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 2007, 27(47):13033-13041.
15. Carosella E.D., Moreau P., Aractingi S., Rouas-Freiss N. HLA-G: A shield against inflammatory aggression. Trends Immunol 2001, 22(10):553-555.
16. Charlton K.M., Casey G.A. Experimental rabies in skunks: Immunofluorescence light and electron microscopic studies. Lab Invest 1979, 41(1):36-44.
17. Charlton K.M., Casey G.A. Experimental rabies in skunks: Persistence of virus in denervated muscle at the inoculation site. Can J Comp Med 1981, 45(4):357-362.
18. Charlton K.M., Casey G.A., Campbell J.B. Experimental rabies in skunks: Effects of immunosuppression induced by cyclophosphamide. Can J Comp Med 1984, 48(1):72-77.
19. Chopy D., Detje C.N., Lafage M., Kalinke U., Lafon M. The type I interferon response bridles rabies virus infection and reduces pathogenicity. J Neurovirol 2011, 17(4):353-367. 10.1007/s13365-011-0041-6.
20. Chopy D., Pothlichet J., Lafage M., Megret F., Fiette L., Si-Tahar M., et al. Ambivalent role of the innate immune response in rabies virus pathogenesis. J Virol 2011, 85(13):6657-6668. doi: JVI.00302-11 [pii] 10.1128/JVI.00302-11.
21. Davoust N., Vuaillat C., Androdias G., Nataf S. From bone marrow to microglia: Barriers and avenues. Trends Immunol 2008, 29(5):227-234. doi: S1471-4906(08)00088-4 [pii] 10.1016/j.it.2008.01.010.
22. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., et al. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 2006, 103(20):7835-7840.
23. Diebold S.S., Montoya M., Unger H., Alexopoulou L., Roy P., Haswell L.E., et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003, 424(6946):324-328. doi: 10.1038/nature01783 nature01783 [pii].
24. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat Med 2002, 8(8):793-800.
25. Eisenacher K., Steinberg C., Reindl W., Krug A. The role of viral nucleic acid recognition in dendritic cells for innate and adaptive antiviral immunity. Immunobiology 2007, 212(9-10):701-714. doi: S0171-2985(07)00112-X [pii] 10.1016/j.imbio.2007.09.007.
26. Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 2008, 14(16):1555-1565.
27. Faber M., Bette M., Preuss M.A., Pulmanausahakul R., Rehnelt J., Schnell M.J., et al. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J Virol 2005, 79(24):15405-15416. doi: 79/24/15405 [pii] 10.1128/JVI.79.24.15405-15416.2005.
28. Faul E.J., Wanjalla C.N., Suthar M.S., Gale M., Wirblich C., Schnell M.J. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog 2010, 6(7):e1001016. 10.1371/journal.ppat.1001016.
29. Fu Z.F., Weihe E., Zheng Y.M., Schafer M.K., Sheng H., Corisdeo S., et al. Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J Virol 1993, 67(11):6674-6681.
30. Galea I., Bechmann I., Perry V.H. What is immune privilege (not)?. Trends Immunol 2007, 28(1):12-18. doi: S1471-4906(06)00326-7 [pii] 10.1016/j.it.2006.11.004.
31. Galelli A., Baloul L., Lafon M. Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis. J Neurovirol 2000, 6(5):359-372.
32. Goethals S., Ydens E., Timmerman V., Janssens S. Toll-like receptor expression in the peripheral nerve. Glia 2010, 58(14):1701-1709. 10.1002/glia.21041.
33. Gratas C., Tohma Y., Barnas C., Taniere P., Hainaut P., Ohgaki H. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 1998, 58(10):2057-2062.
34. Hemachudha T., Wacharapluesadee S., Mitrabhakdi E., Wilde H., Morimoto K., Lewis R.A. Pathophysiology of human paralytic rabies. J Neurovirol 2005, 11(1):93-100.
35. Hicks D.J., Nunez A., Healy D.M., Brookes S.M., Johnson N., Fooks A.R. Comparative pathological study of the murine brain after experimental infection with classical rabies virus and European bat lyssaviruses. J Comp Pathol 2009, 140(2-3):113-126.
36. Hirai K., Kawano H., Mifune K., Fujii H., Nishizono A., Shichijo A., et al. Suppression of cell-mediated immunity by street rabies virus infection. Microbiol Immunol 1992, 36(12):1277-1290.
37. Hooper D.C., Morimoto K., Bette M., Weihe E., Koprowski H., Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 1998, 72(5):3711-3719.
38. Hooper D.C., Phares T.W., Fabis M.J., Roy A. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis 2009, 3(10):e535.
39. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314(5801):994-997.
40. Hunter M., Johnson N., Hedderwick S., McCaughey C., Lowry K., McConville J., et al. Immunovirological correlates in human rabies treated with therapeutic coma. J Med Virol 2010, 82(7):1255-1265. 10.1002/jmv.21785.
41. Ida-Hosonuma M., Iwasaki T., Yoshikawa T., Nagata N., Sato Y., Sata T., et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 2005, 79(7):4460-4469. doi: 79/7/4460 [pii] 10.1128/JVI.79.7.4460-4469.2005.
42. Irwin D.J., Wunner W.H., Ertl H.C., Jackson A.C. Basis of rabies virus neurovirulence in mice: Expression of major histocompatibility complex class I and class II mRNAs. J Neurovirol 1999, 5(5):485-494.
43. Ito N., Moseley G.W., Blondel D., Shimizu K., Rowe C.L., Ito Y., et al. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J Virol 2010, 84(13):6699-6710. doi: JVI.00011-10 [pii]10.1128/JVI.00011-10.
44. Iwasaki Y., Clark H.F. Cell to cell transmission of virus in the central nervous system. II. Experimental rabies in mouse. Lab Invest 1975, 33(4):391-399.
45. Jackson A.C., Scott C.A., Owen J., Weli S.C., Rossiter J.P. Therapy with minocycline aggravates experimental rabies in mice. J Virol 2007, 81:6248-6253.
46. Johnston G.R., Webster N.R. Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth 2009, 102(4):453-462. doi: aep037 [pii] 10.1093/bja/aep037.
47. Kasempimolporn S., Saengseesom W., Mitmoonpitak C., Akesowan S., Sitprija V. Cell-mediated immunosuppression in mice by street rabies virus not restored by calcium ionophore or PMA. Asian Pac J Allergy Immunol 1997, 15(3):127-132.
48. Kasempimolporn S., Tirawatnapong T., Saengseesom W., Nookhai S., Sitprija V. Immunosuppression in rabies virus infection mediated by lymphocyte apoptosis. Jpn J Infect Dis 2001, 54(4):144-147.
49. Kieseier B.C. The mechanism of action of interferon-beta in relapsing multiple sclerosis. CNS Drugs 2011, 25(6):491-502. doi: 10.2165/11591110-000000000-000004 [pii].
50. Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 2007, 282(20):14975-14983. doi: M607277200 [pii] 10.1074/jbc.M607277200.
51. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005, 79(17):11457-11466. doi: 79/17/11457 [pii] 10.1128/JVI.79.17.11457-11466.2005.
52. Klingen Y., Conzelmann K.K., Finke S. Double-labeled rabies virus: Live tracking of enveloped virus transport. J Virol 2008, 82(1):237-245. doi: JVI.01342-07 [pii] 10.1128/JVI.01342-07.
53. Koedel U., Rupprecht T., Angele B., Heesemann J., Wagner H., Pfister H.W., et al. MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain 2004, 127(Pt 6):1437-1445.
54. Kojima D., Park C.H., Satoh Y., Inoue S., Noguchi A., Oyamada T. Pathology of the spinal cord of C57BL/6J mice infected with rabies virus (CVS-11 strain). J Vet Med Sci 2009, 71(3):319-324.
55. Kojima D., Park C.H., Tsujikawa S., Kohara K., Hatai H., Oyamada T., et al. Lesions of the central nervous system induced by intracerebral inoculation of BALB/c mice with rabies virus (CVS-11). J Vet Med Sci 2010, 72(8):1011-1016. doi: JST.JSTAGE/jvms/09-0550 [pii].
56. Kuss S.K., Etheredge C.A., Pfeiffer J.K. Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog 2008, 4(6):e1000082. 10.1371/journal.ppat.1000082.
57. Kwidzinski E., Bunse J., Kovac A.D., Ullrich O., Zipp F., Nitsch R., et al. IDO (indolamine 2,3-dioxygenase) expression and function in the CNS. Adv Exp Med Biol 2003, 527:113-118.
58. Lafon M. Modulation of the immune response in the nervous system by rabies virus. Curr Top Microbiol Immunol 2005, 289:239-258.
59. Lafon M. Immune evasion, a critical strategy for rabies virus. Dev Biol (Basel) 2008, 131:413-419.
60. Lafon M. Evasive strategies in rabies virus infection. Adv Virus Res 2011, 79:33-53. doi: B978-0-12-387040-7.00003-2 [pii] 10.1016/B978-0-12-387040-7.00003-2.
61. Lafon M., Megret F., Lafage M., Prehaud C. The innate immune facet of brain: Human neurons express TLR-3 and sense viral dsRNA. J Mol Neurosci 2006, 29(3):185-194.
62. Lafon M., Megret F., Meuth S.G., Simon O., Velandia Romero M.L., Lafage M., et al. Detrimental contribution of the immuno-inhibitor b7-h1 to rabies virus encephalitis. J Immunol 2008, 180(11):7506-7515.
63. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005, 79(24):15226-15237.
64. Laothamatas J., Wacharapluesadee S., Lumlertdacha B., Ampawong S., Tepsumethanon V., Shuangshoti S., et al. Furious and paralytic rabies of canine origin: Neuroimaging with virological and cytokine studies. J Neurovirol 2008, 14(2):119-129.
65. Li J., Ertel A., Portocarrero C., Barkhouse D.A., Dietzschold B., Hooper D.C., et al. Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues. J Virol 2012, 86(6):3200-3210. doi: JVI.06699-11 [pii] 10.1128/JVI.06699-11.
66. Li J., McGettigan J.P., Faber M., Schnell M.J., Dietzschold B. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway. Vaccine 2008, 26(3):419-426. doi: S0264-410X(07)01262-5 [pii] 10.1016/j.vaccine.2007.10.072.
67. Liu L., Botos I., Wang Y., Leonard J.N., Shiloach J., Segal D.M., et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 2008, 320(5874):379-381. doi: 320/5874/379 [pii] 10.1126/science.1155406.
68. Ma Y., Haynes R.L., Sidman R.L., Vartanian T. TLR8: An innate immune receptor in brain, neurons and axons. Cell Cycle 2007, 6(23):2859-2868.
69. Ma Y., Li J., Chiu I., Wang Y., Sloane J.A., Lu J., et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 2006, 175(2):209-215. doi: jcb.200606016 [pii] 10.1083/jcb.200606016.
70. Marquette C., Van Dam A.M., Ceccaldi P.E., Weber P., Haour F., Tsiang H. Induction of immunoreactive interleukin-1 beta and tumor necrosis factor-alpha in the brains of rabies virus infected rats. J Neuroimmunol 1996, 68(1-2):45-51.
71. Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Abe M., et al. Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity. Virus Res 2010, doi: S0168-1702(10)00352-7 [pii] 10.1016/j.virusres.2010.09.016.
72. Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Sawaki Y., et al. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol 2010, 84(8):4002-4012. doi: JVI.02220-09 [pii] 10.1128/JVI.02220-09.
73. Masatani T., Ito N., Shimizu K., Ito Y., Nakagawa K., Sawaki Y., et al. Rabies Virus Nucleoprotein Functions To Evade Activation of the RIG-I-Mediated Antiviral Response. Journal of Virology 2010, 84(8):4002-4012. 10.1128/Jvi.02220-09.
74. McKimmie C.S., Johnson N., Fooks A.R., Fazakerley J.K. Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem Biophys Res Commun 2005, 336(3):925-933.
75. Megret F., Prehaud C., Lafage M., Moreau P., Rouas-Freiss N., Carosella E.D., et al. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum Immunol 2007, 68(4):294-302.
76. Menager P., Roux P., Megret F., Bourgeois J.P., Le Sourd A.M., Danckaert A., et al. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog 2009, 5(2):e1000315. 10.1371/journal.ppat.1000315.
77. Montano-Hirose J.A., Lafage M., Weber P., Badrane H., Tordo N., Lafon M. Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice. Vaccine 1993, 11(12):1259-1266.
78. Nakamichi K., Inoue S., Takasaki T., Morimoto K., Kurane I. Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. J Virol 2004, 78(17):9376-9388.
79. Nakamichi K., Saiki M., Sawada M., Takayama-Ito M., Yamamuro Y., Morimoto K., et al. Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J Virol 2005, 79(18):11801-11812.
80. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: The missing link in neuroprotection and neurodegeneration?. Nat Rev Neurosci 2002, 3(3):216-227.
81. Nuovo G.J., DeFaria D.L., Chanona-Vilchi J.G., Zhang Y. Molecular detection of rabies encephalitis and correlation with cytokine expression. Mod Pathol 2004.
82. Park C.H., Kondo M., Inoue S., Noguchi A., Oyamada T., Yoshikawa H., et al. The histopathogenesis of paralytic rabies in six-week-old C57BL/6J mice following inoculation of the CVS-11 strain into the right triceps surae muscle. J Vet Med Sci 2006, 68(6):589-595.
83. Park C., Lee S., Cho I.H., Lee H.K., Kim D., Choi S.Y., et al. TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: Differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 2006, 53(3):248-256. 10.1002/glia.20278.
84. Peltier D.C., Simms A., Farmer J.R., Miller D.J. Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J Immunol 2010, 184(12):7010-7021. doi: jimmunol.0904133 [pii] 10.4049/jimmunol.0904133.
85. Perry L.L., Hotchkiss J.D., Lodmell D.L. Murine susceptibility to street rabies virus is unrelated to induction of host lymphoid depletion. Journal of immunology 1990, 144(9):3552-3557.
86. Pfeiffer J.K. Innate host barriers to viral trafficking and population diversity: Lessons learned from poliovirus. Adv Virus Res 2010, 77:85-118. doi: B978-0-12-385034-8.00004-1 [pii] 10.1016/B978-0-12-385034-8.00004-1.
87. Phares T.W., Kean R.B., Mikheeva T., Hooper D.C. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 2006, 176(12):7666-7675.
88. Phares T.W., Stohlman S.A., Hinton D.R., Atkinson R., Bergmann C.C. Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. J Immunol 2010, 185(9):5607-5618. doi: jimmunol.1001984 [pii] 10.4049/jimmunol.1001984.
89. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314(5801):997-1001.
90. Prehaud C., Megret F., Lafage M., Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 2005, 79(20):12893-12904.
91. Pulmanausahakul R., Faber M., Morimoto K., Spitsin S., Weihe E., Hooper D.C., et al. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. J Virol 2001, 75(22):10800-10807. 10.1128/JVI.75.22.10800-10807.2001.
92. Randall R.E., Goodbourn S. Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89(Pt 1):1-47. doi: 89/1/1 [pii] 10.1099/vir.0.83391-0.
93. Rieder M., Brzozka K., Pfaller C.K., Cox J.H., Stitz L., Conzelmann K.K. Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: Inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol 2011, 85(2):842-852. doi: JVI.01427-10 [pii] 10.1128/JVI.01427-10.
94. Rieder M., Conzelmann K.K. Rhabdovirus evasion of the interferon system. J Interferon Cytokine Res 2009, 29(9):499-509.
95. Rossiter J.P., Hsu L., Jackson A.C. Selective vulnerability of dorsal root ganglia neurons in experimental rabies after peripheral inoculation of CVS-11 in adult mice. Acta Neuropathol 2009, 118:249-259.
96. Rouas-Freiss N., Moreau P., Menier C., Carosella E.D. HLA-G in cancer: A way to turn off the immune system. Semin Cancer Biol 2003, 13(5):325-336.
97. Roy A., Hooper D.C. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 2007, 81(15):7993-7998.
98. Roy A., Phares T.W., Koprowski H., Hooper D.C. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 2007, 81(3):1110-1118.
99. Shankar V., Kao M., Hamir A.N., Sheng H., Koprowski H., Dietzschold B. Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus. J Virol 1992, 66(2):992-998.
100. Shimizu K., Ito N., Sugiyama M., Minamoto N. Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene. Microbiol Immunol 2006, 50(12):975-978.
101. Sommereyns C., Paul S., Staeheli P., Michiels T. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008, 4(3):e1000017. 10.1371/journal.ppat.1000017.
102. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296. 10.1146/annurev.iy.09.040191.001415.
103. Sugiura N., Uda A., Inoue S., Kojima D., Hamamoto N., Kaku Y., et al. Gene Expression Analysis of Host Innate Immune Responses in the Central Nervous System following Lethal CVS-11 Infection in Mice. Jpn J Infect Dis 2011, 64(6):463-472.
104. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140(6):805-820. doi: S0092-8674(10)00023-1 [pii] 10.1016/j.cell.2010.01.022.
105. Tang S.C., Arumugam T.V., Xu X., Cheng A., Mughal M.R., Jo D.G., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 2007, 104(34):13798-13803. doi: 0702553104 [pii] 10.1073/pnas.0702553104.
106. Tobiume M., Sato Y., Katano H., Nakajima N., Tanaka K., Noguchi A., et al. Rabies virus dissemination in neural tissues of autopsy cases due to rabies imported into Japan from the Philippines: Immunohistochemistry. Pathol Int 2009, 59(8):555-566.
107. Torres-Anjel M.J., Volz D., Torres M.J., Turk M., Tshikuka J.G. Failure to thrive, wasting syndrome, and immunodeficiency in rabies: A hypophyseal/hypothalamic/thymic axis effect of rabies virus. Rev Infect Dis 1988, 10(Suppl 4):S710-S725.
108. Tracey K.J. Reflex control of immunity. Nature reviews. Immunology 2009, 9(6):418-428. 10.1038/nri2566.
109. Tshikuka J.G., Torres-Anjel M.J., Blenden D.C., Elliott S.C. The microepidemiology of wasting syndrome, a common link to diarrheal disease, cancer, rabies, animal models of AIDS, and HIV-AIDS YHAIDS). The feline leukemia virus and rabies virus models. Ann N Y Acad Sci 1992, 653:274-296.
110. Ugolini G. Specificity of rabies virus as a transneuronal tracer of motor networks: Transfer from hypoglossal motoneurons to connected second-order and higher order central nervous system cell groups. J Comp Neurol 1995, 356(3):457-480.
111. Ugolini G. Advances in viral transneuronal tracing. J Neurosci Methods, Epub ahead of print 2010, doi: S0165-0270(09)00623-2 [pii] 10.1016/j.jneumeth.2009.12.001.
112. Van Dam A.M., Bauer J., Man A., Hing W.K., Marquette C., Tilders F.J., et al. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J Neurosci Res 1995, 40(2):251-260.
113. Versteeg G.A., Garcia-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 2010, 13(4):508-516. doi: S1369-5274(10)00070-6 [pii] 10.1016/j.mib.2010.05.009.
114. Vidy A., El Bougrini J., Chelbi-Alix M.K., Blondel D. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 2007, 81(8):4255-4263.
115. Vuaillat C., Varrin-Doyer M., Bernard A., Sagardoy I., Cavagna S., Chounlamountri I., et al. High CRMP2 expression in peripheral T lymphocytes is associated with recruitment to the brain during virus-induced neuroinflammation. J Neuroimmunol 2008, 193(1-2):38-51.
116. Wang Z.W., Sarmento L., Wang Y., Li X.Q., Dhingra V., Tseggai T., et al. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 2005, 79(19):12554-12565.
117. Weiland F., Cox J.H., Meyer S., Dahme E., Reddehase M.J. Rabies virus neuritic paralysis: Immunopathogenesis of nonfatal paralytic rabies. J Virol 1992, 66(8):5096-5099.
118. Wen Y., Wang H., Wu H., Yang F., Tripp R.A., Hogan R.J., et al. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J Virol 2011, 85(4):1634-1644. doi: JVI.01552-10 [pii] 10.1128/JVI.01552-10.
119. Wiktor T.J., Doherty P.C., Koprowski H. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc Natl Acad Sci U S A 1977, 74(1):334-338.
120. Wiktor T.J., Doherty P.C., Koprowski H. Suppression of cell-mediated immunity by street rabies virus. J Exp Med 1977, 145(6):1617-1622.
121. Wiktor T.J., Macfarlan R.I., Reagan K.J., Dietzschold B., Curtis P.J., Wunner W.H., et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A 1984, 81(22):7194-7198.
122. Wunner W.H., Dietzschold B., Curtis P.J., Wiktor T.J. Rabies subunit vaccines. J Gen Virol 1983, 64(Pt 8):1649-1656.
123. Xiang Z.Q., Knowles B.B., McCarrick J.W., Ertl H.C. Immune effector mechanisms required for protection to rabies virus. Virology 1995, 214(2):398-404.
124. Zhang B., Chan Y.K., Lu B., Diamond M.S., Klein R.S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol 2008, 180(4):2641-2649. doi: 180/4/2641 [pii].
125. Zhao L., Toriumi H., Kuang Y., Chen H., Fu Z.F. The Roles of Chemokines in Rabies Virus Infection: Over-Expression May Not Always Be Beneficial. J Virol. 2009.
126. Zhao P., Zhao L., Zhang T., Qi Y., Wang T., Liu K., et al. Innate immune response gene expression profiles in central nervous system of mice infected with rabies virus. Comp Immunol Microbiol Infect Dis 2011, doi: S0147-9571(11)00077-4 [pii] 10.1016/j.cimid.2011.09.003.